Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?

Documenti analoghi

• A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
  di: Durez, P, et al.
  Pubblicazione: (2004)
• Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?
  di: Buttgereit, F, et al.
  Pubblicazione: (2005)
• Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?
  di: Hider, S, et al.
  Pubblicazione: (2003)
• Methotrexate related adverse effects in patients with RA
  di: Ranganathan, P, et al.
  Pubblicazione: (2005)
• Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?
  di: Yazici, Y, et al.
  Pubblicazione: (2004)